Press releases | WebDisclosure

Basculer en Français

10429	Companies
218410	Keywords
147914	Articles
115545	Press releases

Home
Press releases

PRESS RELEASE

published on 04/09/2025 at 07:40, 1 year 1 month ago

RTG Mining Inc. Announces Issue Of A$4.2 million Chess Depository Instruments Under Placement
RTG Mining Inc. issues 169,297,750 Securities at A$0.025 per Security to investors in successful Placement. Shareholder approval sought for Tranche 2 Securities. About RTG Mining Inc. and future opportunities

Shareholder Approval Placement RTG Mining Inc. Mabilo Project Panguna Project
PRESS RELEASE

published on 04/09/2025 at 07:30, 1 year 1 month ago

Sensirion opens additional production building in Debrecen
Sensirion opens additional production building in Debrecen, Hungary to increase production capacity for sensor modules and strengthen position as an employer. Sustainable technology and new jobs created

Sensirion Debrecen Sustainable Technology Production Building Sensor Modules
PRESS RELEASE

published on 04/09/2025 at 07:30, 1 year 1 month ago

Iute Group Starts Conditional Exchange And Cash Tender Offer For New EUR 2025/2030 Bonds
Iute Group launches conditional exchange and cash tender offer for new EUR 2025/2030 Bonds, offering bondholders reinvestment or cash exit option. Minimum participation threshold set at EUR 75 million

Iute Group Exchange Cash Tender Conditional Offer EUR 2025/2030 Bonds
PRESS RELEASE

published on 04/09/2025 at 07:30, 1 year 1 month ago

Bluelinea publie ses résultats annuels 2024 et son chiffre d'affaires du 1er trimestre 2025
Bluelinea présente ses résultats annuels 2024, sa trésorerie et son chiffre d'affaires du T1 2025. Malgré un contexte économique difficile, l'entreprise a amélioré ses performances

Chiffre D'affaires Croissance Résultats Annuels Trésorerie Bluelinea
PRESS RELEASE

published on 04/09/2025 at 07:30, 1 year 1 month ago

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
OSE Immunotherapeutics to present new data on Lusvertikimab's long-term benefits and safety in ulcerative colitis at DDW 2025, showcasing potential in autoimmune diseases

Ulcerative Colitis Immuno-oncology Inflammatory Diseases OSE Immunotherapeutics Lusvertikimab
PRESS RELEASE

published on 04/09/2025 at 07:30, 1 year 1 month ago

OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la “Digestive Disease Week” (DDW) 2025
OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la Digestive Disease Week (DDW) 2025

Rectocolite Hémorragique OSE Immunotherapeutics Lusvertikimab Anticorps Monoclonal Efficacité Et Sécurité
PRESS RELEASE

published on 04/09/2025 at 07:01, 1 year 1 month ago

Press release: Leonteq enters the market for listed leverage products in Switzerland
Leonteq announces the market launch of listed leverage products in Switzerland, listing over 2,500 products on SIX Swiss Exchange and planning expansion on BX Swiss

Switzerland Leonteq SIX Swiss Exchange Market Launch Listed Leverage Products
PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 1 month ago

ARYZTA issues AGM invitation
ARYZTA AG issues invitation to Annual General Meeting (AGM) scheduled for 09.04.2025. The international bakery company is based in Schlieren, Switzerland, with operations worldwide

SIX Swiss Exchange ARYZTA AG AGM Invitation Bakery Company Schlieren Switzerland
REGULATED PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 1 month ago

Biophytis confirme le lancement de l’essai clinique de Phase 2 OBA dans l’obésité
Biophytis confirme le lancement de l'essai clinique de Phase 2 OBA dans l'obésité en 2025, avec BIO101. Recherche d'un partenaire pharmaceutique pour le développement et le lancement du produit aux États-Unis

Biophytis Essai Clinique BIO101 Obésité Partenaire Pharmaceutique
REGULATED PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 1 month ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Biophytis confirms the Phase 2 OBA Clinical Trial launch in obesity, continuing development of BIO101 to reduce muscle strength loss. Seeking pharmaceutical partner for co-development

Biophytis BIO101 Obesity Pharmaceutical Partner Phase 2 OBA Clinical Trial

Accesswire

Published on 05/20/2026 at 03:21, 2 hours 34 minutes ago

Challenger Assays Extend New Open Pittable Mineralisation
Published on 05/20/2026 at 00:00, 5 hours 55 minutes ago

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 10 hours 10 minutes ago

Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 13 hours 8 minutes ago

Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 14 hours 40 minutes ago

Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion

View all ACCESSWIRE

EQS Group

Published on 05/19/2026 at 21:24, 8 hours 30 minutes ago

EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 10 hours 5 minutes ago

EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 10 hours 15 minutes ago

PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 10 hours 50 minutes ago

Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 10 hours 59 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/19/2026 at 18:45, 11 hours 10 minutes ago

Finalisation de la cession de Novacel
Published on 05/19/2026 at 18:45, 11 hours 10 minutes ago

Closing of the sale of Novacel
Published on 05/19/2026 at 18:34, 11 hours 20 minutes ago

Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 18:34, 11 hours 20 minutes ago

Mise à disposition des documents préparatoires à l’assemblée générale annuelle mixte des actionnaires du 9 juin 2026
Published on 05/19/2026 at 18:30, 11 hours 24 minutes ago

TERACT- Communiqué InVivo Group - Retrait obligatoire

View all LES ECHOS COMFI WIRE